Guardant Health
GH
#1548
Rank
NZ$23.24 B
Marketcap
NZ$178.97
Share price
1.68%
Change (1 day)
189.94%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: NZ$23.24 Billion

As of December 2025 Guardant Health has a market cap of NZ$23.24 Billion. This makes Guardant Health the world's 1548th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$23.24 B248.54%
2024NZ$6.66 B28.45%
2023NZ$5.19 B18.31%
2022NZ$4.38 B-70.52%
2021NZ$14.88 B-16.64%
2020NZ$17.85 B63.89%
2019NZ$10.89 B126.72%
2018NZ$4.80 B

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of Guardant Health was reported to be:

NZ$22.18 Billion
by Nasdaq info icon info icon
NZ$22.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Natera
NTRA
NZ$54.93 B 136.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
NZ$2.54 B-89.07%๐Ÿ‡บ๐Ÿ‡ธ USA